You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ophthalmic antihypertensives

Showing 1 - 25 of 1,115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Open-angle Glaucoma Trial in Bogotá, Zapopan (PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic)

Recruiting
  • Primary Open-angle Glaucoma
  • Bogotá, Bogotá D.C., Colombia
  • +1 more
Dec 22, 2021

Pre-Eclampsia, Hypertension in Pregnancy, Pregnancy Complications Trial in Honolulu (Furosemide, Placebo)

Completed
  • Pre-Eclampsia
  • +3 more
  • Honolulu, Hawaii
    Kapiolani Medical Center for Women and Children
Apr 29, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost

Not yet recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Travoprost Ophthalmic Topical Cream low-dose
  • +4 more
  • Newport Beach, California
    Glaukos Clinical Study Site
Nov 22, 2023

Primary Hypertension Trial (Amlodipine, Olmesartan, Hydrochlorothiazide)

Not yet recruiting
  • Primary Hypertension
  • (no location specified)
Jun 15, 2023

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Glendale, Newport Beach, Cranberry Township (SBI-100 Ophthalmic

Recruiting
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • SBI-100 Ophthalmic Emulsion, 0.5%
  • +2 more
  • Glendale, California
  • +2 more
Nov 17, 2023

Glaucoma, Open-Angle, Hypertension, Ocular Trial in Austin (NCX 470, Latanoprost 0.005%)

Completed
Has Results
  • Glaucoma, Open-Angle
  • Hypertension, Ocular
  • NCX 470
  • Latanoprost 0.005%
  • Austin, Texas
    Texan Eye
Nov 9, 2022

Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • Topical spironolactone ophthalmic solution, 0.005 mg/cc
  • Placebo
  • Bellaire, Texas
    Richard W Yee, MD PLLC
Aug 16, 2023

Hypertension, Menopause Trial in Uberlandia (Combined exercise)

Terminated
  • Hypertension
  • Menopause
  • Combined exercise
  • Uberlandia, Minas Gerais, Brazil
    Guilherme Morais Puga
Mar 7, 2022

Stroke, Medication Adherence Trial in Kumasi (Polycap)

Not yet recruiting
  • Stroke
  • Medication Adherence
  • Kumasi, Ghana
    Kwame Nkrumah Institute of Science & Technology
Jul 19, 2023

Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of

Completed
Has Results
  • Conjunctivitis, Allergic
  • ADX-102 Ophthalmic Drops (0.5%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Dec 14, 2022

Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • MDI-1228_mesylate Ophthalmic Solution
  • Placebo
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jul 24, 2023

Anesthesia, Local Trial in McAllen (AG-920, Proparacaine Ophthalmic)

Completed
  • Anesthesia, Local
  • McAllen, Texas
    American Genomics Site 2
Sep 21, 2022

Healthy Adult Males Volunteers Trial in Osaka (STN1012600 ophthalmic solution 0.002%)

Recruiting
  • Healthy Adult Males Volunteers
  • STN1012600 ophthalmic solution 0.002%
  • Osaka, Japan
    Medical Corporation Heishinkai OPHAC Hospital
Jun 6, 2023

Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, STN1012600 ophthalmic solution

Recruiting
  • Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%
  • Aichi, Japan
  • +15 more
Aug 16, 2022

Diabetic Retinopathy Trial in Puerto Rico, United States (OTT166, Vehicle control)

Recruiting
  • Diabetic Retinopathy
  • Peoria, Arizona
  • +65 more
Jan 25, 2023

Open Angle Glaucoma Trial (NCX 470, Placebo)

Not yet recruiting
  • Open Angle Glaucoma
  • NCX 470
  • Placebo
  • (no location specified)
Jul 6, 2023

Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

Not yet recruiting
  • Allergic Conjunctivitis
  • rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
  • Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
  • (no location specified)
Apr 4, 2023

Autism Spectrum Disorder, Ophthalmic Abnormalities Trial in Istanbul (Gluten Free Casein Free Diet)

Completed
  • Autism Spectrum Disorder
  • Ophthalmic Abnormalities
  • Gluten Free Casein Free Diet
  • İstanbul, Turkey
    Üsküdar University
May 5, 2023

Dry Eye Syndromes, Dry Eye Disease, Kerato Conjunctivitis Sicca Trial (5% Tavilermide ophthalmic solution, Vehicle ophthalmic

Not yet recruiting
  • Dry Eye Syndromes
  • +2 more
  • 5% Tavilermide ophthalmic solution
  • Vehicle ophthalmic solution
  • (no location specified)
Apr 27, 2023

Diabetic Macular Edema Trial in Beverly Hills (Active treatment arm: OCS-01 (dexamethasone), Vehicle)

Active, not recruiting
  • Diabetic Macular Edema
  • Active treatment arm: OCS-01 (dexamethasone)
  • Vehicle
  • Beverly Hills, California
    Oculis Investigative Site
Jan 13, 2023

Dry Eye Disease Trial in Andover, Shelby, Memphis (SI-614, Vehicle)

Recruiting
  • Dry Eye Disease
  • Newport Beach, California
  • +6 more
Jan 22, 2023

Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)

Completed
  • Dry Eye Disease
  • Reproxalap Ophthalmic Solution (0.25%)
  • Placebo Comparator
  • Andover, Massachusetts
    Andover Eye Associates
Jan 24, 2023

Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System

Recruiting
  • Cataract
  • +2 more
  • Bimatoprost Implant System (High Dose)
  • +4 more
  • Glendale, Arizona
    Arizona Advanced Eye Research Institute
Nov 8, 2023

Dry Eye Disease Trial (OK-101, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Mar 8, 2023

Antiseptics, Microbiota, Conjunctiva Trial in Brescia (Povidone-Iodine 0.66%, Chlorhexidine 0.02%)

Completed
  • Antiseptics
  • +2 more
  • Povidone-Iodine 0.66%
  • Chlorhexidine 0.02%
  • Brescia, Italy
    Azienda Socio Sanitaria Territoriale degli Spedali Civili di Bre
Aug 2, 2023